Condition
Carcinomas|Amyloidosis|Anal Cancer|Anemia|Cholangiocarcinoma of the Extrahepatic Bile Duct|Transitional Cell Carcinoma of Bladder|Bone Marrow Transplant Failure|Bone Cancer|Cancer of Brain and Nervous System|Breast Cancer|Carcinoma of the Large Intestine|Endocrine Cancer|Esophageal Cancer|Eye Cancer|Gall Bladder Cancer|Gastric (Stomach) Cancer|Gastrooesophageal Cancer|Gastrointestinal Stromal Tumor (GIST)|Gynecologic Cancers|Head and Neck Cancers|Hepatobiliary Neoplasm|Kidney (Renal Cell) Cancer|Leukemia|Lung Cancer|Hodgkin Disease|Lymphoma, Non-Hodgkin|Mesothelioma|Multiple Myeloma|Myelodysplastic Syndromes (MDS)|Neuroendocrine Tumors|Myeloproliferative Disorders|Pancreatic Cancer|Prostate Cancer|Skin Cancer|Soft Tissue Sarcoma|Testicular Cancer|Thymus Cancer|Thyroid Cancer
Estimated Enrollment: 99
Age Group: up to 40 Years (Child, Adult)
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective
Study ID Numbers: PEDSVAR0038|SU-11172008-1345
Study First Received: June 1, 2010
Last Updated: November 16, 2015
Estimated Primary Completion Date: October 2010
Primary Outcome Measures:
Development of cardiomyopathy
Sponsors and Collaborators:
Daniel Bernstein|Stanford University
Website Link: https://ClinicalTrials.gov/show/NCT01135849
